Your one-stop Solution for MEDICAL LEARNING & UPDATES

hidoc_medibot hidoc_medibot

Today's Updates

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

Published Date: 04 Nov 2026

The HCPFive: Top News for Healthcare Providers from the Week of 10/25

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Published Date: 04 Nov 2026

Q&A: Asthma Remission from Year 1 To Year 2 With Depemokimab

Deep TMS Reduces Suicidal Ideation by 70% in MDD, With Owen Muir, MD Owen Muir, MD, DFAACAP, FCTMSS

Published Date: 04 Nov 2026

A secondary analysis found the SWIFT accelerated protocol eased suicidal ideation faster than standard daily deep TMS dosing in major depressive disorder.

Benitec Reports Positive Interim Results for BB-301 in Oculopharyngeal Muscular Dsytrophy Marco Meglio

Published Date: 04 Nov 2026

Interim phase 1b/2a data showed all patients treated with high- or low-dose BB-301 for oculopharyngeal muscular dystrophy met formal response criteria.

This Week on NeurologyLive® — November 2, 2026 Isabella Ciccone, MPH

Published Date: 04 Nov 2026

Here's some of what is coming soon to NeurologyLive® this week.

Zola-Cel and Treatment-Free Remission: What the BREAKFREE-2 Data Show Marco Meglio, Jeffrey Cohen, MD

Published Date: 04 Nov 2026

Jeffrey Cohen, MD, professor of neurology and staff physician at the Cleveland Clinic Mellen Center for Multiple Sclerosis, discusses interim BREAKFREE-2 findings for zola-cel, a CD19-directed CAR T cell therapy, in relapsing and progressive MS.

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

Published Date: 04 Nov 2026

ASN Kidney Week 2026 Recap: 8 Key Updates in Kidney Disease to Know

Knowledge Hub

Oncology

Engineered Lymphoid Tissue Niches for Reconstructing Immune-Supportive Microenvironments After Cancer Treatment 

A medical review of engineered lymphoid tissue niches for restoring immune function after cancer treatment, including mechanisms, clinical applications, risks, and emerging research.

Oncology

Monitoring Delayed Toxicities of Cellular Cancer Therapies 

A clinical review of delayed toxicities after cellular cancer therapy, including mechanisms, risk factors, diagnosis, management, and guideline-based long-term surveillance.

Oncology

Genomic Determinants of Tumor Cell Dormancy in Minimal Residual Cancer Disease 

A medical review of genomic, epigenetic, immune, and microenvironmental mechanisms governing tumor dormancy in minimal residual cancer disease.

Oncology

Therapeutic Advances in Tumor Nutrient-Deprivation Strategies 

A medical review of tumor nutrient-deprivation therapies, including mechanisms, clinical applications, emerging treatments, safety, biomarkers, and future directions.

Oncology

Virtual Oncology Survivorship Support Networks: Evidence, Clinical Integration, and Future Directions

Oncology

Precision Selection of Cancer Surgery Versus Organ-Preserving Treatment Using Patient-Specific Functional Priorities

Oncology

Pathophysiology of Tumor Interstitial Fluid Accumulation

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Dr. Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Dr. Harish P and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Dr Vijay Agarwal and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Dr Suvir Singh

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Dr. Todd Bauer and 1 more

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Dr. Poonam Patil and 1 more

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot